News
Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.
Three patients with a muscle-wasting disease died from liver failure after taking the therapy, Elevidys, or a similar ...
The FDA granted breakthrough therapy designation to first-line treatment with Enhertu plus Perjeta for unresectable or metastatic HER2+ breast cancer.
Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results